StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Boston Scientific (BSX) Announces Late-Breaking Data for HeartLogic Heart Failure Diagnostic
September 19, 2017 9:26 AM
Boston Scientific (NYSE: BSX) today announced new data from the Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients (MultiSENSE) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Management Comments
Next Articles
Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the HeartLogicâ„¢ Heart Failure Diagnostic
September 19, 2017 9:24 AM